| Document Date: 2012-10-25 05:59:57 Open Document File Size: 2,30 MBShare Result on Facebook
City Munich / Hannover / Cambridge / Darmstadt / Hamburg / Santa Cruz / / Company Epitomics Inc. / Merck / BD Biosciences / Sigma-Aldrich / Macmillan Publishers Limited / / Country Germany / United States / United Kingdom / / / Facility TRAIL DISC / C terminus / Disease TRAIL / TRAIL C230S / Helmholtz Center / TRAIL M Grunert1 / C terminus of TRAIL-R1 / / / IndustryTerm active site / p43 cleavage product / cellular systems / cleavage site / chemical mutagenesis / protease cleavage site / / MedicalCondition tumor / Disease / SHEP neuroblastoma cells / increased inflammation / tumor necrosis / JURKAT T-cell leukemia / T-cell leukemia / Experimental Medicine Tumor necrosis factor / RIP1 deficiency / deficiency / TRAIL-sensitive neuroblastoma cell line SHEP / FADD deficiency / / MedicalTreatment anticancer therapy / / Organization Helmholtz Center Munich / Department of Gene Vectors / German Research Center for Environmental Health / DED / / Person Carl Roth / Gene Vectors / / / Position *Corresponding author / representative / reporter / Harper / / Technology antibodies / siRNA / Cell Signaling / DNA binding / apoptosis / / URL www.nature.com/cddis / /
SocialTag |